A polymorphic microsatellite that mediates induction of PIG3 by p53
The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
The gene PIG3 is induced by the tumor suppressor p53 but not by p53 mutants unable to induce apoptosis, suggesting its involvement in p53-mediated cell death. Here we show that p53 directly binds and activates the PIG3 promoter, but not through the previously described DNA element. Instead, p53 interacts with a pentanucleotide microsatellite sequence within the PIG3 promoter (TGYCC)n where Y=C or T. Despite its limited similarity to the p53-binding consensus, this sequence is necessary and sufficient for transcriptional activation of the PIG3 promoter by p53 and binds specifically to p53 in vitro and in vivo. In a population of 117 healthy donors from Germany, the microsatellite was found to be polymorphic, the number of pentanucleotide repeats being 10, 15, 16 or 17, and the frequency of alleles 5.1%, 62.0%, 21.4% and 11.5%, respectively. The number of repeats directly correlated with the extent of transcriptional activation by p53. This is the first time that a microsatellite has been shown to mediate the induction of a promoter through direct interaction with a transcription factor. Moreover, this sequence of PIG3 is the first p53-responsive element found to be polymorphic. Inheritance of this microsatellite may affect an individual's susceptibility to cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Expression levels of the p53 targets CDKN1A and TP53I314,15 were markedly lower in the TP53-targeted cluster (Figure 2c)”
From On the design of CRISPR-based single-cell molecular screens (2018) · cites this paper as [15]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
A simplified system for generating recombinant adenoviruses
He, T.-C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W., & Vogelstein, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.5.2509 · Cited by 3,206
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500 · cited 1×
“gif" NDATA ITEM> ]> The gene PIG3 is induced by the tumor suppressor p53 but not by p53 mutants unable to induce apoptosis, suggesting its involvement in p53-mediated cell deat”
BackgroundShi, Y., Seto, E., Chang, L.-S., & Shenk, T. (1991) · Cell · doi:10.1016/0092-8674(91)90189-6 · Cited by 1,035
Regulation of the specific DNA binding function of p53
Hupp, T. R., Meek, D. W., Midgley, C. A., & Lane, D. P. (1992) · Cell · doi:10.1016/0092-8674(92)90562-q · Cited by 909
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
A transcriptionally active DNA-binding site for human p53 protein complexes.
Funk, W. D., Pak, D. T., Karas, R. H., Wright, W. E., & Shay, J. W. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.6.2866 · Cited by 732
Lin, J., Chen, J., Elenbaas, B., & Levine, A. J. (1994) · Genes & Development · doi:10.1101/gad.8.10.1235 · Cited by 653
Roth, J., Dobbelstein, M., Freedman, D. A., Shenk, T., & Levine, A. J. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.554 · Cited by 610
Self-citationThe polyproline region of p53 is required to activate apoptosis but not growth arrest
Sakamuro, D., Sabbatini, P., White, E., & Prendergast, G. C. (1997) · Oncogene · doi:10.1038/sj.onc.1201263 · Cited by 316 · cited 1×
“In parallel, these mutants are unable to induce apoptosis but are still capable of inducing cell-cycle arres”
Background
Cited by
Items 101–200 of 269
The transcription factor CREBZF is a novel positive regulator of p53
López-Mateo, I., Villaronga, M. Á., Llanos, S., & Belandia, B. (2012) · Cell Cycle · doi:10.4161/cc.22133 · Cited by 36
p53 binding sites in normal and cancer cells are characterized by distinct chromatin context
Bao, F., LoVerso, P. R., Fisk, J. N., Zhurkin, V. B., & Cui, F. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1361064 · Cited by 41
“Second, p53 can bind to different motifs such as microsatellites in the PIG3 gene.(43) Third, p53 can be recruited”
Analysis of p53 “Latency” and “Activation” by Fluorescence Correlation Spectroscopy
Woelcke, J., Reimann, M., Klumpp, M., Göhler, T., Kim, E. L., & Deppert, W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303615200 · Cited by 36
Llanos, S., Royer, C., Lu, M. M., Bergamaschi, D., Lee, W. H., & Lü, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.270751 · Cited by 35
Wang, S., Wang, M., Yin, S., Fu, G., Li, C., Chen, R., Li, A., Zhou, J., Zhang, Z., & Liu, Q. (2007) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2007.08.011 · Cited by 37
A novel response element confers p63- and p73-specific activation of the WNT4 promoter
Osada, M., Park, H. L., Nagakawa, Y., Begum, S., Yamashita, K., Wu, G., Kim, M. S., Trink, B., & Sidransky, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.118 · Cited by 36
Kirschner, R. D., Sänger, K., Müller, G. A., & Engeland, K. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn132 · Cited by 34
“EMSAs were carried out as previously described (53).”
MethodHannan, A. J. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5434-2_1 · Cited by 42
Yeo, S. Y., Itahana, Y., Guo, A. K., Han, R., Iwamoto, K., Nguyen, T., Bao, Y., Kleiber, K., Wu, Y., Bay, B., et al. (2016) · eLife · doi:10.7554/elife.07101 · Cited by 36
“, 2009), underscoring the complexity of the TP53 network (Contente et al., 2002; Jordan et al., 2008; Menendez et al., 2013; Tebaldi et al., 2015).”
BackgroundGu, M., Gao, D., Yao, P., Yu, L., Yang, X., Xing, C., Zhou, J., Shang, Z., & Li, M. (2018) · Cancer Science · doi:10.1111/cas.13818 · Cited by 32
Fuzzy Tandem Repeats Containing p53 Response Elements May Define Species-Specific p53 Target Genes
Simeonova, I., Lejour, V., Bardot, B., Bouarich-Bourimi, R., Morin, A., Fang, M., Charbonnier, L., & Toledo, F. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002731 · Cited by 35
“In the murine Rbl2 gene, 6 out of 7 p53 half-sites are perfect matches to the consensus, thus exceeding by far the proposed criteria for clustered p53 binding half-sites; 2) transactivation was shown to occur through p53 binding to repeated sequences such as retroviral elements for a fraction of p53 target genes [21,2…”
BackgroundRother, K., Dengl, M., Lorenz, J., Tschöp, K., Kirschner, R. D., Mössner, J., & Engeland, K. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.028 · Cited by 31
Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson
Menéndez, D., Inga, A., Jordan, J. J., & Resnick, M. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210277 · Cited by 40
“There are now several examples of human diversity in the p53 network that are due to changes in REs (Contente et al., 2002; Tomso et al., 2005).”
BackgroundChaudhry, S. R., Lopes, J. L., Levin, N. K., Kalpage, H. A., & Tainsky, M. A. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00442-y · Cited by 32
Grapotte, M., Saraswat, M., Bessière, C., Menichelli, C., Ramilowski, J. A., Severin, J., Hayashizaki, Y., Itoh, M., Tagami, M., Murata, M., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23143-7 · Cited by 37
“At the molecular level, STRs can for instance affect expression by inducing inhibitory DNA structures 26 and/or by modulating TF binding 27,28 .”
BackgroundKumazawa, T., Tsuchiya, N., Wang, L., Sato, K., Kamoto, T., Ogawa, O., Nakamura, A., Kato, T., & Habuchi, T. (2004) · International Journal of Cancer · doi:10.1002/ijc.20070 · Cited by 33
“Prostate cancer 278 37 (13) 81 (29) 118 (42) 160 (58) Stage(2) A B C 170 27 (16) 54 (32) 81 (48) 89 (52) D 108 10 (9) 27 (25) 37 (34) 71 (66) A B 118 21 (18) 38 (32) 59 (50) 59 (50) C D 160 16 (10) 43 (27) 59 (37) 101 (63) Grade(3) Low-intermediate 163 26 (16) 55 (42) 81 (50) 82 (50) High 103 11 (11) 26 (25) 37 (36) 6…”
Ranathunge, C., Wheeler, G. L., Chimahusky, M. E., Perkins, A., Pramod, S., & Welch, M. E. (2020) · Molecular Ecology · doi:10.1111/mec.15440 · Cited by 34
PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway
Xu, J., Cai, J., Jin, X., Yang, J., Shen, Q., Ding, X., & Liang, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.4096 · Cited by 27
HEY1 Leu94Met gene polymorphism dramatically modifies its biological functions
Villaronga, M. Á., Lavery, D. N., Bevan, C. L., Llanos, S., & Belandia, B. (2009) · Oncogene · doi:10.1038/onc.2009.309 · Cited by 27
“Hence, we chose the PIG3-luciferase reporter for further characterization of the functional connection between HEY1 and p53.”
MethodInfluentialCoufal, J., Jagelská, E. B., Liao, J. C. C., & Brázda, V. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.015 · Cited by 29
PIG3 promotes NSCLC cell mitotic progression and is associated with poor prognosis of NSCLC patients
Li, M., Li, S., Liu, B., Gu, M.-M., Zou, S., Xiao, B.-B., Yu, L., Ding, W., Zhou, P., Zhou, J., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0508-2 · Cited by 30
“sequence ((TGYCC)n, Y = C or T) that is the p53binding cis-element and mediates p53-induced transactivation of PIG3 [9].”
Giraud, M., Beaurain, G., Eymard, B., Tranchant, C., Gajdos, P., & Garchon, H. (2004) · Genes and Immunity · doi:10.1038/sj.gene.6364110 · Cited by 27
Variable number tandem repeats – Their emerging role in sickness and health
Marshall, J. N. G., Lopez, A. I., Pfaff, A. L., Kõks, S., Quinn, J. P., & Bubb, V. J. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211003511 · Cited by 32
Gene Regulation as a Modulator of Social Preference in Voles
Hammock, E. A. D. (2007) · Advances in genetics · doi:10.1016/s0065-2660(07)59004-8 · Cited by 26
Ding, W., Tong, Y., Zhang, X., Pan, M., & Chen, S. (2016) · Scientific Reports · doi:10.1038/srep19793 · Cited by 27
Nicholls, C. D., Shields, M. A., Lee, P. W. K., Robbins, S. M., & Beattie, T. L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401049200 · Cited by 28
Mende, M., Christophorou, N., & Streit, A. (2008) · Mechanisms of Development · doi:10.1016/j.mod.2008.08.005 · Cited by 27
“…observed with pRFPRNAi vectors is due to activation of the p53 pathway, which leads to apoptosis via PIG3 and CDM2 (Bose and Ghosh, 2007; Contente et al., 2002; LaFleur et al., 2002; Polyak et al., 1997) and cell cycle arrest via CIP1/p21 (Sherr and Roberts, 1995; Waldman et al., 1995).”
Guan, X., Liu, Z., Wang, L., Johnson, D. G., & Wei, Q. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.12.124 · Cited by 25
“Our recent study indicated that (TGYCC)15, the most common wild-type allele, led to the most effective transcriptional activity of the promoter, compared to the other three variant (TGYCC)n motifs [3], but a previous study observed a direct linear correlation between the expression levels and the number of the (TGYCC)…”
BackgroundSaidj, D., Cros, M., Hernández‐Vargas, H., Guarino, F., Sylla, B. S., Tommasino, M., & Accardi, R. (2013) · Journal of Virology · doi:10.1128/jvi.01047-13 · Cited by 24
“ChIP experiments revealed H3Lys27 hypermethylation in the PIG3 promoter region surrounding the p53RE, as well as in the PIG3 coding sequence region ( 322/ 492), which contains a microsatellite region that has been proposed as a p53 binding site (29) (Fig.”
BackgroundInsights into the Mitochondrial Signaling Pathway: What Lessons for Chemotherapy?
Brenner, C., Bras, M. L., & Kroemer, G. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1022541009662 · Cited by 24
A promoter that acquired p53 responsiveness during primate evolution.
Contente, A., Zischler, H., Einspanier, A., & Dobbelstein, M. (2003) · PubMed · Cited by 24
Self-citationp53-Dependent Apoptosis and NAD(P)H:Quinone Oxidoreductase 1
Asher, G., Lotem, J., Sachs, L., & Shaul, Y. (2004) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)82016-0 · Cited by 24
Adaptive protein evolution through length variation of short tandem repeats in Arabidopsis
Reinar, W. B., Greulich, A., Stø, I. M., Knutsen, J. B., Reitan, T., Tørresen, O. K., Jentoft, S., Butenko, M. A., & Jakobsen, K. S. (2023) · Science Advances · doi:10.1126/sciadv.add6960 · Cited by 24
Jiang, Y., Shan, S., Chi, L., Zhang, G., Gao, X., Li, H., Zhu, X., & Yang, J. J. (2015) · Tumor Biology · doi:10.1007/s13277-015-3531-y · Cited by 23
“PIG-3 promoter ((TGYCC) n, where Y=C or T) that is required for the transcriptional activation of this promoter by p53 [27].”
Liu, L., & Hastings, J. W. (2006) · Journal of Phycology · doi:10.1111/j.1529-8817.2006.00165.x · Cited by 23
“Similarly, the promoter of all ribosomal genes resides in the intergenic region (Sollner-Webb and Tower 1986), which is in the range of 1881 nt in the ascidian urochordate (Degnan et al. 1998) to 30 kb in humans (Gonzalez et al. 1992).”
BackgroundSTRs: Ancient Architectures of the Genome beyond the Sequence
Gharesouran, J., Hosseinzadeh, H., Ghafouri‐Fard, S., Taheri, M. N., & Rezazadeh, M. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01850-6 · Cited by 25
“Additionally, this study applied multiple methods to show that binding of p53 as a tumor suppressor to the STR was essential and adequate for transcription, the frequency of which was associated with the repeat copy number (Contente et al. 2002).”
BackgroundMethodXiao, X., Zhang, C., Zhang, Z., Hu, Z., Li, M., & Li, T. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01329-1 · Cited by 23
Serum withdrawal up‐regulates human SIRT1 gene expression in a p53‐dependent manner
Shang, L., Zhou, H., Xia, Y., Wang, H., Gao, G., Chen, B., Liu, Q., Shao, C., & Gong, Y. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00468.x · Cited by 21
“Although some p53binding sites match the consensus sequence quite well, others can be consensus poor and yet they are all essential, and efficient, in the transactivating process [29].”
BackgroundChen, P., He, G., Zou, X., Wang, M., Jia, F., Bai, H., Li, J., Yu, J., & Han, Y. (2018) · PLoS ONE · doi:10.1371/journal.pone.0204286 · Cited by 20
Human Microsatellites: Mutation and Evolution
Tv, N., & Nazarenko, S. A. (2004) · Russian Journal of Genetics · doi:10.1023/b:ruge.0000044750.21421.65 · Cited by 20
“A direct evidence for the MS involvement in transcription regulation was obtained in 2002 by a German research team: pentanucleotide polymorphic sequence (TGYCC)Qn, where Y = C or T, located in the promoter region of gene PIG3, proved to be the site of binding of and transcription activation by tumor suppressor p53 [5…”
Identification of p53-target genes in Danio rerio
Mandriani, B., Castellana, S., Rinaldi, C., Manzoni, M., Venuto, S., Rodríguez-Aznar, E., Galcerán, J., Nieto, M. A., Borsani, G., Monti, E., et al. (2016) · Scientific Reports · doi:10.1038/srep32474 · Cited by 30
Mutual Interference of Adenovirus Infection and myc Expression
Löhr, K., Hartmann, O., Schäfer, H., & Dobbelstein, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7936-7944.2003 · Cited by 19
Self-citationStudies on modulation of the activity of tumor suppressor protein p53
Kadaja, L. (2004) · DSpace repository (University of Tartu) · Cited by 219
STRScan: targeted profiling of short tandem repeats in whole-genome sequencing data
Tang, H., & Nzabarushimana, É. (2017) · BMC Bioinformatics · doi:10.1186/s12859-017-1800-z · Cited by 25
“Even the STRs in non-coding regions may be involved in the expression regulation of their downstream genes [12].”
BackgroundBöhlig, L., Metzger, R. P., Rother, K., Till, H., & Engeland, K. (2008) · Cell Cycle · doi:10.4161/cc.7.9.5812 · Cited by 19
PIG3 Regulates p53 Stability by Suppressing Its MDM2-Mediated Ubiquitination
Jin, M., Park, S., Kim, S. W., Kim, H., Hyun, J. W., & Lee, J.-H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.086 · Cited by 19
“p53 binds to a penta-nucleotide microsatellite sequence within the PIG3 promoter and thereby transactivates the expression of PIG3 prior to the onset of p53-initated apoptosis (Contente et al., 2002).”
BackgroundOketch, J. W., Wain, L. V., & Hollox, E. J. (2024) · PLoS ONE · doi:10.1371/journal.pone.0300545 · Cited by 22
Kotsinas, A., Evangelou, K., Sideridou, M., Kotzamanis, G., Constantinides, C. A., Zavras, A. I., Douglass, C. W., Papavassiliou, A. G., & Gorgoulis, V. G. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.10.013 · Cited by 20
“Similar microsatellites, located in non-coding regions of genes, that also exhibit a length-dependent influence on their function, have been described in the EGFR [21], PIG3 [22] and H-ras genes [23,24].”
BackgroundAL-Eitan, L. N., Almasri, A. Y., & Al-Habahbeh, S. (2019) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s189838 · Cited by 17
“These VNTR polymorphisms can regulate gene expression in a number of ways: inhibiting or promoting gene expression by modifying transcription factors or other binding site proteins; and change in the structure of the DNA, such as the variation in the distance between the functional units.(21,22) VNTR polymorphisms oft…”
BackgroundHeshmati, Y., Mirabzadeh, A., Feizzade, G., Gilanipour, M., Etminan, M. R., Khorshid, H. R. K., Kamali, K., Fakhri, M., Moghimi, N., Najmabadi, H., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30805 · Cited by 18
“They can act variously as (i) functional elements binding to transcription factors and other proteins that inhibit or promote expression [Lesch et al., 1994; Contente et al., 2002], or (ii) elements having physical effects, such as varying the spacing between functional motifs or altering the structure and melting pro…”
BackgroundCharacterization of the target DNA sequence for the DNA-binding domain of zinc finger protein 191
Wang, H., Sun, R., Liu, G., Yao, M., Fei, J., & Shen, H. (2008) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/40.8.704 · Cited by 17
Microsatellites with Macro-Influence in Ewing Sarcoma
Monument, M. J., Johnson, K. M., Grossmann, A. H., Schiffman, J. D., Randall, R. L., & Lessnick, S. L. (2012) · Genes · doi:10.3390/genes3030444 · Cited by 19
“However to date, no functional role for PIG3 has been defined in tumorigenesis [63,64].”
BackgroundKrackow, S., & König, B. (2007) · Behavioral Ecology and Sociobiology · doi:10.1007/s00265-007-0507-y · Cited by 17
“This implies that expression differences result from conformational changes caused by the length of repetitive elements, as is well known from mini- and microsatellite effects in other contexts (Goldstein and Schlötterer 1999; Contente et al. 2002).”
BackgroundReactivation of mutant p53 by a one-hybrid adaptor protein.
Roth, J. C., Lenz-Bauer, C., Contente, A., Löhr, K., Koch, P., Bernard, S., & Dobbelstein, M. (2003) · PubMed · Cited by 16
Self-citationWu, Z., Gong, H., Zhou, Z., Jiang, T., Lin, Z., Li, J., Xiao, S., Yang, B., & Huang, L. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00658-z · Cited by 16
CYP2C9 Promoter Variable Number Tandem Repeat Polymorphism Regulates mRNA Expression in Human Livers
Wang, D., Sun, X., Gong, Y., Gawronski, B. E., Langaee, T. Y., Shahin, M. H., Khalifa, S. I., & Johnson, J. A. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.044255 · Cited by 16
“…factors or other protein binding sites and inhibiting or promoting gene expression; and 2) changing DNA structure, such as varying the spacing between functional motif or altering the structure and melting properties of DNA in their proximity (Lesch et al., 1994; Contente et al., 2002).”
Müller, G. A., Heißig, F., & Engeland, K. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl210 · Cited by 15
“It has been shown that a functional microsatellite length developed only with apes and humans (Contente et al. 2002).”
BackgroundInfluentialUguen, K., Michaud, J. L., & Génin, E. (2024) · European Journal of Human Genetics · doi:10.1038/s41431-024-01666-z · Cited by 17
“Variations in STRs can modulate the binding of transcription factors [31], change the distance between regulatory elements [30], alter splicing [32], modify epigenetic marks [13] or induce unusual secondary DNA structures that could affect transcription [33].”
Gorgoulis, V. G., Liloglou, T., Sigala, F., Korkolis, D. P., Yannoukakos, D., Papalambros, E. L., Asimacopoulos, P. J., Papavassiliou, A. G., & Kotsinas, A. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.07.008 · Cited by 14
Zhang, Z., Yang, Z., Wang, S., Wang, X., & Mao, J. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102932 · Cited by 18
The p53HMM algorithm: using profile hidden markov models to detect p53-responsive genes
Riley, T., Yu, X., Sontag, E. D., & Levine, A. J. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-111 · Cited by 13
“These affinity measurements were obtained by mutating or truncating p53 cluster-sites in the genes DDB2, and TP53i3 [20,21].”
MethodLandefeld, C. C., Hodgkinson, C. A., Spagnolo, P. A., Marietta, C. A., Shen, P., Sun, H., Zhou, Z., Lipska, B. K., & Goldman, D. A. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0120-z · Cited by 13
Boehden, G. S., Baumann, C., Siehler, S. Y., & Wiesmüller, L. (2005) · Oncogene · doi:10.1038/sj.onc.1208592 · Cited by 13
“…does not stimulate recombination at the (CTG)98 repeat p53 has been linked to repeat sequences in several ways: p53 directly binds and activates the PIG3 promoter through a pentanucleotide microsatellite sequence with limited similarity to the p53 consensus sequence (Contente et al., 2002).”
BackgroundBras, M. L., Bensaad, K., & Soussi, T. (2003) · Oncogene · doi:10.1038/sj.onc.1206424 · Cited by 13
“1BD, Scotland Oncogene (2003) 22, 5082–5090 & 2003 Nature Publishing Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc O N C O G E N O M IC S polymorphic microsatellite sequence localized in the promoter (Contente et al., 2002).”
BackgroundInfluentialAssociation of the PIG3 Promoter Polymorphism with Invasive Bladder Cancer in a Japanese Population
Ito, M., Nishiyama, H., Watanabe, J., Kawanishi, H., Takahashi, T., Kamoto, T., Habuchi, T., & Ogawa, O. (2006) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyi225 · Cited by 12
“It was demonstrated in an in vitro study that the PIG3 promoter VNTRs is directly bound by TP53, and that the activity of PIG3was influenced according to the number of repeats within it (14).”
InfluentialMeloni, R., Biguet, N. F., & Mallet, J. J. (2002) · Molecular Neurobiology · doi:10.1385/mn:26:2-3:389 · Cited by 12
“The binding of p53 to this sequence induces the transcriptional activation of the PIG3 gene that is correlated to the number of repeats (86).”
BackgroundAllelic Loss of a Common Microsatellite MarkerMYCL1
Kambara, T., Sharp, G. B., Nagasaka, T., Takeda, M., Sasamoto, H., Nakagawa, H., Isozaki, H., MacPhee, D. G., Jass, J. R., Tanaka, N., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0779-3 · Cited by 11
“There is evidence that p53 regulates the PIG3 promoter at a pentanucleotide repeat and that different polymorphisms in this repeat influence transcription of PIG3 (31).”
BackgroundDe novo emergence and potential function of human-specific tandem repeats in brain-related loci
Kim, K., Bang, S., Yoo, D., Kim, H., & Suzuki, S. (2019) · Human Genetics · doi:10.1007/s00439-019-02017-5 · Cited by 10
Quan, J., Li, Y., Jin, M., Chen, D., Jin, M., & Jin, M. (2017) · Tumor Biology · doi:10.1177/1010428317694572 · Cited by 10
Flow cytometric detection of tandem repeat mutations induced by various chemical classes
Healy, C., Wade, M., McMahon, A., Williams, A., Johnson, D. A., & Parfett, C. L. J. (2006) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2006.01.012 · Cited by 10
Kinney, N. A., Kang, L., Bains, H., Lawson, E., Husain, M., Husain, K., Sandhu, I., Shin, Y., Carter, J. K., Anandakrishnan, R., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249148 · Cited by 9
“Longer repeats resulted in more efficient transcriptional activation through p53 promoter binding [11].”
Backgroundde Boer, I., Harder, A. V. E., Ferrari, M. D., van den Maagdenberg, A. M. J. M., & Terwindt, G. M. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823356-6.00012-3 · Cited by 10
Nomdedeu, J. F., Perea, G., Estivill, C., Lasa, A., Brunet, S., Aventin, A. M., & Sierra, J. (2004) · Leukemia · doi:10.1038/sj.leu.2403379 · Cited by 9
Zhou, C., Li, F., Wen, Q., Price, M., Yang, N., & Yue, B. (2021) · Mammal Research · doi:10.1007/s13364-021-00563-w · Cited by 8
Breen, G. D., Collier, D. A., Craig, I., & Quinn, J. P. (2008) · IEEE Engineering in Medicine and Biology Magazine · doi:10.1109/emb.2008.915501 · Cited by 8
“[ 7 ] M. Romney, ‘‘Republican: Mitt Romney,’’ Science, vol.”
BackgroundGuan, X., Liu, Z., Wang, L., Wang, L., Sturgis, E. M., & Wei, Q. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs388 · Cited by 10
“However, in the previous report with the biliary cancer CAK-1 cells (8), the PIG3 promoter activity appeared to be increased as the number of the PIG3 (TGYCC)n motif increased in the presence of experimentally induced p53 overexpression, a scenario that may mimic cellular stress response.”
BackgroundResultInfluentialGet ready for short tandem repeats analysis using long reads-the challenges and the state of the art
Chaushevska, M., Alapont-Celaya, K., Schack, A. K., Krych, Ł., Garrido-Navas, M. C., Krithara, A., & Madjarov, G. (2025) · Frontiers in Genetics · doi:10.3389/fgene.2025.1610026 · Cited by 11
Oppel, F., Shao, S., Gendreizig, S., Zimmerman, M. W., Schürmann, M., Flavian, V. F., Goon, P. K. C., Chi, S. N., Aster, J. C., Sudhoff, H. H., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0770 · Cited by 8
Das, B., Nagano, K., Kawai, G., Murata, A., & Nakatani, K. (2021) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.1c02383 · Cited by 8
Regression based predictor for p53 transactivation
Gowrisankar, S., & Jegga, A. G. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-215 · Cited by 9
The oncogenic effects of p53-inducible gene 3 (PIG3) in colon cancer cells
Park, S., Kim, H.-B., Kim, J., Park, S.-G., Kim, S. W., & Lee, J.-H. (2017) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2017.21.2.267 · Cited by 7
“, showed that PIG3 was induced by the transcriptional activation of p53 through direct binding to a pentanucleotide microsatellite sequence within the PIG3 promoter (TGYCC)n where Y=C or T [3].”
BackgroundWang, C., Kubiak, Ł., Du, L., Li, W., Jian, Z., Tang, C., Fan, Z., Zhang, X., & Yue, B. (2016) · Gene · doi:10.1016/j.gene.2016.08.047 · Cited by 7
Pospı́šilová, Š., Siligan, C., Ban, J., Jug, G., & Kovar, H. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.296.2.5 · Cited by 7
“Recently, however, a pentanucleotide polymorphic microsatellite sequence further downstream (+442 to +516) has been shown to bind to p53 and to be necessary and sufficient to mediate pig3 gene activation (27).”
BackgroundResultInfluentialZhang, G., & Andersen, E. C. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad067 · Cited by 7
“…STR variation on regulation of gene expression have also been suggested from both in vitro and in vivo studies across a wide range of taxa (Weiser et al. 1989; Rothenburg et al. 2001; Contente et al. 2002; Rockman and Wray 2002; Sureshkumar et al. 2009; Vinces et al. 2009; Yáñez-Cuna et al. 2014).”
BackgroundQin, X., Zhang, S.-M., Li, B. J., Liu, X.-D., He, X.-P., Shang, Z., Xu, Q.-Z., Zhao, Z., Ye, Q.-N., & Zhou, P. (2011) · Chinese Science Bulletin · doi:10.1007/s11434-011-4702-x · Cited by 6
McKinney, K. M., & Prives, C. L. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6_2 · Cited by 10
“Recently a p53 response element in a microsatellite sequence of the PIG3 promoter which contains 10-17 tandem repeats of the pentanucleotide sequence (TGPyCC)n (Contente et al., 2002) was identified.”
BackgroundWydorski, P. J., Żmijewska, A., & Franczak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25136931 · Cited by 7
“It was found that increased ROS production is correlated with the expression of tumor protein p53 inducible protein 3 ( TP53I3 , formally known as PIG3 ) [50,51].”
BackgroundChatzidavid, S., Kontandreopoulou, C., Giannakopoulou, N., Diamantopoulos, P. T., Stafylidis, C., Kyrtsonis, M., Dimou, M., Panayiotidis, P. G., & Viniou, N. (2024) · Advances in Hematology · doi:10.1155/2024/1370364 · Cited by 5
Freewoman, J. M., Snape, R., & Cui, F. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1904554 · Cited by 5
“It has been shown that p53 interacts with a pentanucleotide microsatellite sequence within the PIG3 promoter (TGYCC)n where Y = C or T [70].”
BackgroundSacco, J., Danielson, S. M., & Toral, K. (2017) · Canine Genetics and Epidemiology · doi:10.1186/s40575-017-0050-8 · Cited by 5
“Tandem repeats can modulate GSTP1 expression by changing the copy number of binding sites for transcription factors, as has been observed with the binding of Sp1 to the human EGF gene [49], the interactions of Sp1 and AP2 to the human RFC gene [50], and the binding of p53 to PIG3 [51].”
Non-hominid TP63 lacks retroviral LTRs but contains a novel conserved upstream exon
Beyer, U., & Dobbelstein, M. (2011) · Cell Cycle · doi:10.4161/cc.10.12.15838 · Cited by 5
Self-citationHMOX1 STR polymorphism and malaria: an analysis of a large clinical dataset
Hamilton, F., Mitchell, R. E., Cunnington, A. J., Ghazal, P., & Timpson, N. J. (2022) · Malaria Journal · doi:10.1186/s12936-022-04352-x · Cited by 4
Ultrastable and versatile multimeric ensembles of FoxP3 on microsatellites
Leng, F., Merino‐Urteaga, R., Wang, X., Zhang, W., Ha, T., & Hur, S. (2025) · Molecular Cell · doi:10.1016/j.molcel.2025.03.005 · Cited by 5
“1,2,5 11 Many microsatellites are evolutionarily enriched in gene-proximal cis -regulatory elements, 9,12,13 and (cid:1) 90% of transcription factors (TFs) tested, in particular those with the forkhead DNA-binding domain (DBD), have demonstrated the ability to bind specific microsatellites both in…”
Why is p53-inducible gene 3 rarely affected in cancer?
Kotsinas, A., Pateras, I. S., Galanos, P., Karamouzis, M. V., Sfikakis, P. P., & Gorgoulis, V. G. (2010) · Oncogene · doi:10.1038/onc.2010.263 · Cited by 4
“An individual’s constitution or deregulation of this repetitive sequence, by microsatellite instability (MSI), was postulated as potential mechanisms for cancer susceptibility (Contente et al., 2002).”
BackgroundPhenotypic Associations With the HMOX1 GT(n) Repeat in European Populations
Hamilton, F., Mitchell, R. E., Ghazal, P., & Timpson, N. J. (2023) · American Journal of Epidemiology · doi:10.1093/aje/kwad154 · Cited by 4
“Second, a genomewide analysis of 2,060 expression short tandem repeats found linear associations to be the most common association between STRs and gene expression—a finding also identified in other studies of human STRs (36, 47–49).”
BackgroundMicrosatellite Repeats: Canaries in the Coalmine
Chatterjee, N., Santillan, B. A., & Wilson, J. H. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6280-4_7 · Cited by 7
Nomdedeu, J. F., Perea, G., Estivill, C., Badell, I., Lasa, A., & Aventin, A. M. (2007) · Leukemia Research · doi:10.1016/j.leukres.2007.01.023 · Cited by 4
Mechanisms of Anticancer Drug Action
Wesselborg, S., & Lauber, K. (2006) · Springer eBooks · doi:10.1007/0-387-23695-3_2 · Cited by 4
Evidence of transcription at polyT short tandem repeatsPreprint
Bessière, C., Saraswat, M., Grapotte, M., Menichelli, C., Ramilowski, J. A., Severin, J., Hayashizaki, Y., Itoh, M., Hasegawa, A., Suzuki, H., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/634261 · Cited by 4
p53-dependent chromatin relaxation is required for DNA double-strand break repair
Chen, H., Shan, J., Qi, W., Chen, L., & Zeng, X. (2025) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2025008 · Cited by 9
“In addition, recent work has revealed that specific p53 molecules bind to microsatellite sequences with limited similarity to the p53 consensus sequence, which may significantly increase the number of genomic p53 - binding sites [43].”
Metadata
- Authors
- Contente, A., Dittmer, A., Koch, M. C., Roth, J., & Dobbelstein, M.
- Affiliations
- Philipps University of Marburg (DE)
- Corresponding author
- Dobbelstein, Matthias
- Venue
- Nature Genetics
- Published
- 2002-02-04
- Volume
- 30
- Issue
- 3
- Pages
- 315-320
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2092863749
- Cited by
- 274
- References
- 23
- Citations by year
- 2025: 7 · 2024: 5 · 2023: 8 · 2022: 19 · 2021: 9 · 2020: 2 · 2019: 7 · 2018: 11 · 2017: 12 · 2016: 8 · 2015: 9 · 2014: 4 · 2013: 9 · 2012: 11
- FWCI
- 8.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- PIG3, p53, microsatellite polymorphism, promoter activation, transcriptional activation, p53 response elements, pentanucleotide repeats, p53 binding, cancer susceptibility, genetic polymorphism, allele frequency
- MeSH terms
- Base Sequence, Cells, Cultured, Gene Expression Regulation, Humans, Polymorphism, Genetic, Precipitin Tests, Promoter Regions, Genetic, Proteins, Proto-Oncogene Proteins, Tumor Suppressor Protein p53, Microsatellite Repeats, Reverse Transcriptase Polymerase Chain Reaction, Electrophoretic Mobility Shift Assay, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.